Member Info for Yorkshirepragma

Just see biotech M&A .

Https://www.morphosys.com/en/our-pipeline

Acquired $3bn

Plus declared ‘ interest ‘ vis RNS

2+2=?

Wm . With compelling data and already emerging interest .

As an old bold pharma…rare as hens teeth tech.

GLA

Be HG1 … tone down

That’ll upset t’shoot?

T , Eccles are from’t Tother place , tha means Fat Rascal ..eh

?

Https://www.exscientia.ai/pipeline

One can but hope.. RNS material and co presentations are the sole source imho.

LDA , ‘interest already’ … commercial directors appointment RNS.. say no more

ES, ,yes often ‘silence is golden ‘ . The most telling point is ‘ already interest expressed ‘ in recent RNS @ new appointment of commercial role.

Https://www.targetedonc.com/view/fda-grants-orphan-drug-designation-to-ava6000-in-soft-tissue-sarcoma#

DRUG. Antibody.. apologies .

Article reflects the value of lesser effects etc

Https://www.biopharmadive.com/news/fda-roche-polivy-lymphoma-first-line-approval/648184/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202023-04-20%20BioPharma%20Dive%20%5Bissue:49809%5D&utm_term=BioPharma%20Dive

Transition comment telling….appointment gets the ‘ducks in a row’..

AS et al tactics appear to be aggressive forward thinking.

GLA

Look no further than last RNS…clues in the text.

Avacta is at a pivotal point, having recently announced clinical data that have already begun to generate interest from potential commercial partners. I am delighted to be joining at such an exciting point in the journey of the business, to help the team optimise the commercial opportunities of their technologies and assets."

LLP, yes sets the scene a little. If there’s nil interest at present ‘then I’ll go to sea’…

Time will set the agenda sooner rather than later I suspect.

GLA

Https://www.baybridgebio.com/biotech-ipos.html

Only quality clinical stage cos…..?

C, …indeed potentially complex , but in this case there’s a track record ,so differ kettle of fish to some extent.

Plus fast track potential stateside etc.

GLA

DTW,

Well said …new dev role brilliantly flagged the ‘ interest’ in deals going forward @ his confirmation in role RNS.

Imminent deals will see this run ..

Regards